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ARTICLE
Regulation of Gating and Rundown of HCN Hyperpolarization-activated 
Channels by Exogenous and Endogenous PIP2
Phillip Pian,1 Annalisa Bucchi,2 Richard B. Robinson,2,3 and Steven A. Siegelbaum1,2,4
1Center for Neurobiology and Behavior, 2Department of Pharmacology, 3Center for Molecular Therapeutics, 
and 4Howard Hughes Medical Institute, Columbia University Medical Center, New York, NY 10032
The voltage dependence of activation of the HCN hyperpolarization-activated cation channels is shifted in inside-
out patches by −40 to −60 mV relative to activation in intact cells, a phenomenon referred to as rundown. Less 
than 20 mV of this hyperpolarizing shift can be due to the infl  uence of the canonical modulator of HCN channels, 
cAMP. Here we study the role of phosphatidylinositol 4,5-bisphosphate (PI(4,5)P2) in HCN channel rundown, as 
hydrolysis of PI(4,5)P2 by lipid phosphatases is thought to underlie rundown of several other channels. We fi  nd 
that bath application of exogenous PI(4,5)P2 reverses the effect of rundown, producing a large depolarizing shift 
in HCN2 activation. A synthetic short chain analogue of PI(4,5)P2, dioctanoyl phosphatidylinositol 4,5-bisphos-
phate, shifts the HCN2 activation curve to more positive potentials in a dose-dependent manner. Other dioctanoyl 
phosphatidylinositides with one or more phosphates on the lipid headgroup also shift activation, although phos-
phatidylinositol (PI) is ineffective. Several lines of evidence suggest that HCN2 is also regulated by endogenous 
PI(4,5)P2: (a) blockade of phosphatases slows the hyperpolarizing shift upon patch excision; (b) application of an 
antibody that binds and depletes membrane PIP2 causes a further hyperpolarizing shift in activation; (c) the shift 
in activation upon patch excision can be partially reversed by MgATP; and (d) the effect of MgATP is blocked by 
wortmannin, an inhibitor of PI kinases. Finally, recordings from rabbit sinoatrial cells demonstrate that diC8 
PI(4,5)P2 delays the rundown of native HCN currents. Thus, both native and recombinant HCN channels are regu-
lated by PI(4,5)P2.
INTRODUCTION
The HCN channel gene family (HCN1–4) encodes the 
hyperpolarization-activated cation channels that gen-
erate the excitatory pacemaker current (Ih or If), which 
contributes to the rhythmic activity of both neurons 
and cardiac myocytes (Robinson and Siegelbaum, 
2003; DiFrancesco, 2006). Cyclic AMP has long been 
known to directly enhance Ih by shifting its activation 
to more positive potentials (DiFrancesco and Tortora, 
1991). More recently, HCN channel function has been 
found to be regulated by several other mechanisms, in-
cluding tyrosine phosphorylation (Yu et al., 2004; Zong 
et al., 2005; Arinsburg et al., 2006); association with 
MiRP1, a potential HCN channel β subunit (Yu et al., 
2001); and association with TRIP8b, a cytoplasmic pro-
tein that controls channel traffi  cking (Santoro et al., 
2004). Despite the discovery of these new modes of 
Ih regulation, several lines of evidence, including the 
phenomenon of channel rundown, suggest the exis-
tence of other regulatory mechanisms that have yet to 
be identifi  ed.
The activation of Ih shifts by as much as −40 to −60 
mV relative to that in intact cells during recordings 
from inside-out patches or during prolonged dialysis 
associated with whole-cell recordings, for both native 
HCN channels in cardiac myocytes (DiFrancesco et al., 
1986; DiFrancesco and Tortora, 1991; DiFrancesco and 
Mangoni, 1994; Bois et al., 1997) and recombinant 
channels in heterologous cells (Chen et al., 2001). In 
contrast, this rundown phenomenon is not observed 
in perforated-patch whole-cell recordings, suggesting 
that rundown may be due to the loss of intracellular 
constituents that regulate Ih in intact cells (Zhou and 
Lipsius, 1993). Since cAMP produces, at most, a 20-mV 
positive shift in the activation of Ih, loss of a modula-
tory infl  uence of cyclic nucleotides after patch excision 
can account for no more than half of the 40–60-mV 
shift seen during rundown (DiFrancesco and Tortora, 
1991; Chen et al., 2001), suggesting the presence of 
other modulatory factors. Neither MiRP1 (Yu et al., 
2001) nor TRIP8b (Santoro et al., 2004) are likely can-
didates for this factor since these proteins do not act to 
shift HCN activation gating to more positive potentials 
in intact cells. Although overexpression of Src tyrosine 
kinase in HEK-293 cells does shift the voltage depen-
dence of HCN channel activation to more positive 
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  potentials (Arinsburg et al., 2006), loss of Src activity is 
also unlikely to underlie rundown because pharmaco-
logical inhibition of endogenous Src has relatively little 
effect on the voltage dependence of HCN channel ac-
tivation in intact cells (Zong et al., 2005; Arinsburg 
et al., 2006). Thus, the identity of the regulatory mech-
anism responsible for the rundown of Ih activation 
  remains unclear.
Interestingly, rundown may be of physiological rele-
vance since a −40-mV hyperpolarizing shift in HCN 
channel activation is observed in intact ventricular myo-
cytes during postnatal development (Robinson et al., 
1997) and this shift does not appear to be due to changes 
in basal cAMP concentration (Qu et al., 2001). More-
over, during heart failure, HCN channel activation in 
ventricular myocytes shifts back toward more positive 
potentials, producing a proarrhythmic increase in pace-
maker current (Cerbai et al., 1997).
One promising candidate molecule for underlying run-
down is the membrane phospholipid, phosphatidylino-
sitol 4,5-bisphosphate (PI(4,5)P2). Although PI(4,5)P2 
was initially discovered as a precursor for two other 
second messengers, inositol trisphosphate and diac-
ylglycerol, it has more recently been shown to play an 
active role in cellular physiology, including enzyme ac-
tivation, membrane traffi  cking, and, more specifi  cally, 
the regulation of ion channels (Hilgemann et al., 2001; 
McLaughlin et al., 2002; Suh and Hille, 2005). Here we 
examine the hypothesis that the hyperpolarizing shift in 
HCN channel gating upon patch excision results from 
the loss of a basal regulatory action of PI(4,5)P2 during 
rundown due to lipid dephosphorylation by membrane-
bound phosphatases. Such a mechanism has been previ-
ously found to underlie the functional changes observed 
upon patch excision for a variety of other ion channels, 
including inward rectifying K+ channels (Zhang et al., 
1999) and P/Q-type voltage-gated Ca2+ channels (Wu 
et al., 2002; Suh and Hille, 2005).
To address this hypothesis, we examined both recom-
binant HCN2 channels expressed in Xenopus oocytes 
and native HCN currents in cardiac sinoatrial cells. We 
employed several techniques to manipulate membrane 
levels of PI(4,5)P2 in both excised patches and whole 
oocytes, while monitoring the consequences on HCN2 
gating. The results from these experiments are consis-
tent with the idea that HCN2 and native sinoatrial HCN 
currents are regulated by both exogenous and endoge-
nous PI(4,5)P2.
MATERIALS AND METHODS
Expression in Xenopus Oocytes
Mouse HCN2 was previously cloned into pGEMHE (Chen et al., 
2001) and the HCN2/FPN mutant was previously constructed 
(Zhou et al., 2004). PIP5K (phosphatidylinositol-4-phosphate 5-
kinase) in the pGEMHE vector was the generous gift of the Logo-
thetis laboratory. pGEMHE:HCN2 and pGEMHE:PIP5K were 
linearized by SphI and HpaI, respectively. cRNA was transcribed 
from linearized DNA using T7 RNA polymerase (mMessage 
mMachine; Ambion) and injected into Xenopus oocytes as described 
previously (Goulding et al., 1992). Oocytes were injected with 
5 ng HCN2 cRNA; in coexpression experiments, oocytes were 
  injected with 20 ng HCN2 and 20 ng PIP5K cRNA.
Xenopus Oocyte Electrophysiological Recordings
Cell-free inside-out patches were obtained 5–6 d after cRNA 
  injection, and data were acquired using a patch-clamp amplifi  er 
(Axopatch 200B; Axon Instruments, Inc.). Patch pipettes had 
  resistances of 1–3 MΩ and were fi  lled with a pipette solution 
  containing (in mM) 96 KCl, 1 NaCl, 10 HEPES, 1.8 CaCl2, and 
1 MgCl2, pH 7.4. The bath solution contained 96 KCl, 1 NaCl, 
10 HEPES, and 5 EGTA, pH 7.4. The FV bath solution used to in-
hibit phosphatases contained 96 KCl, 0.4 NaCl, 10 HEPES, 5 EGTA, 
0.1 KF, 0.2 Na3VO4, pH 7.4. An Ag-AgCl ground wire was con-
nected to the bath solution by a 3 M KCl agar bridge electrode, 
and junction potential was compensated before the formation 
of each patch. Linear leak current was not subtracted. Data were 
fi  ltered at 1 kHz with an 8-pole low-pass Bessel fi  lter (Frequency 
Devices) and sampled at 2 kHz with an ITC-16 interface 
(Instrutech) and Pulse software (HEKA).
Two microelectrode voltage-clamp recordings were obtained 
1 d after cRNA injection using an oocyte clamp amplifi  er (model 
OC-725C; Warner Instruments). Data were fi  ltered at 1 kHz and 
sampled at 2 kHz. The recordings were obtained with the oocytes 
bathed in an extracellular solution containing (in mM) 96 KCl, 
2 NaCl, 10 HEPES, and 2 MgCl2, pH 7.5. Microelectrodes were 
fi  lled with 3 M KCl and had resistances of 0.5–2 MΩ.
Hyperpolarizing voltages in 10-mV step increments were ap-
plied to either inside-out patches or intact oocytes from a holding 
potential of −30 mV. All recordings were obtained at room 
 temperature (18–22°C).
Data Analysis
HCN currents were analyzed as previously described (Chen et al., 
2001). Activation curves were determined from plots of tail cur-
rent amplitude (measured at −40 mV) as a function of test volt-
age during 3-s hyperpolarizing steps. Activation curves were fi  t with a 
Boltzmann equation to obtain the midpoint voltage of activation 
(V1/2) and slope factor (s) of the relation (both in units of mV). 
Dose–response curves plotting the magnitude of the shift in 
V1/2 as a function of diC8 PI(4,5)P2 concentration were measured 
and fi  tted with the Hill equation to obtain the maximal shift in 
V1/2 at saturating lipid concentration, the concentration of lipid 
producing a half-maximal shift (K1/2), and the Hill coeffi  cient (h). 
Analysis was done using PulseFit (HEKA), Excel (Microsoft), and 
Origin (Microcal). Single comparisons between two experimen-
tal conditions were evaluated by a Student’s t test. Comparisons 
involving multiple populations were evaluated by ANOVA with a 
Scheffe Post-Hoc test.
Experiments on Rabbit Sinoatrial Cells
Animal protocols conformed to the guidelines for the care and 
use of laboratory animals (National Institutes of Health publica-
tion no. 85–23). Rabbit sinoatrial cells were isolated as reported 
(DiFrancesco et al., 1986). Whole-cell patch-clamp experiments 
were performed using pipettes with a resistance of 2.5–4 MΩ 
fi  lled with a solution containing (in mM) 130 aspartic acid, 146 
KOH, 10 NaCl, 2 CaCl2, 5 EGTA-KOH, 2 Mg-ATP, and 10 HEPES-
KOH, pH 7.2. Cells were superfused with an extracellular solu-
tion containing 140 NaCl, 2.3 NaOH, 1 MgCl2, 5.4 KCl, 1.8 CaCl2, 
5 HEPES, 10 glucose, 2 MnCl2, and 1 BaCl2, pH 7.4. Currents 
were recorded and fi  ltered on-line at 1 kHz with an Axopatch 
200B amplifi  er, and acquired using pClamp 9.0 software (Axon 
Instruments, Inc.). Recordings were performed at 32°C.  Pian et al.  595
Activation curves were measured using a two-step protocol in 
which voltage steps from −25 to −115 or −145 mV were applied 
from a holding potential of −35 mV, followed by a step to −70 mV. 
To allow HCN channels to reach steady-state activation at all volt-
ages, the duration of test steps varied from 10 s at −25 mV to 5 s 
at −145 mV while the duration of the step to −70 mV increased 
from 8 to 13.5 s after steps from more hyperpolarized voltages. 
The normalized plot of tail current versus test voltage was fi  tted 
with a Boltzmann function to obtain the V1/2 and slope factor. 
Values are given as the mean ± SEM and data were compared 
  using Student’s t test for single comparisons and two-way ANOVA 
followed by a Bonferroni Post-Hoc test for multiple comparisons. 
Values of P < 0.05 were considered signifi  cant.
Reagents and Drugs
An aqueous stock solution of 0.5 mM native PI(4,5)P2 (Calbio-
chem) was sonicated and aliquoted before snap freezing in liquid 
nitrogen. Aliquots were stored at −80°C until the day of the ex-
periment, when working solutions were sonicated a second time. 
Dioctanoyl (diC8) forms of PI, PI(4)P, PI(3,4)P2, PI(4,5)P2, and 
PI(3,4,5)P3 (Echelon) were dissolved in water to make 2.5 mM 
stock solutions and stored in aliquots at −80°C. Oleoyl CoA 
(Sigma-Aldrich) was dissolved in water at a concentration of 5 mM. 
Anti-PIP2 mAb and anti-hGM-CSF Ab (Assay Designs) were 
stored at −20°C at a concentration of 0.909 μg/μl. Antibodies 
were diluted 1:30 with bath solution to make working solutions. 
Heat-inactivated anti-PIP2 mAb was prepared using a 90-min incu-
bation in a 95°C water bath. Wortmannin (Sigma-Aldrich) was dis-
solved in DMSO at a concentration of 30 mM and stored in 
aliquots at −20°C. LY294002 (Biomol) was dissolved in DMSO at 
a concentration of 50 mM and stored in aliquots at −20°C. Poly-
d-lysine HBr with a molecular weight of 1–4 kD was applied to 
patches at a fi  nal concentration of 25 μg/ml. Materials were pur-
chased from Sigma-Aldrich unless otherwise noted.
Online Supplemental Material
Additional experimental data (available online at http://www.
jgp.org/cgi/content/full/jgp.200609648/DC1) show the effect 
of rundown on the V1/2 of HCN2 (Fig. S1) and the effect of phos-
phatidylinositides on maximal tail current amplitude (Fig. S2).
RESULTS
Exogenous Phosphatidylinositol Phosphates Alter 
the Voltage-dependent Gating of HCN2 Channels
Hyperpolarization-activated currents were elicited by 
a series of 3-s hyperpolarizing test pulses in membrane 
patches from Xenopus oocytes expressing HCN2. The 
midpoint voltage of activation from tail current activa-
tion curves (V1/2) was approximately −80 mV when re-
corded in cell-attached patches before patch excision 
or from intact oocytes using two-microelectrode voltage 
clamp (Chen et al., 2001). However, within 1 min of for-
mation of an inside-out patch, the V1/2 had shifted by 
−40 mV, to approximately −120 mV. The V1/2 was then 
stable over the next 10 min, indicating that this run-
down in the voltage dependence of activation rapidly 
reached completion (Fig. S1, available at http://www.
jgp.org/cgi/content/full/jgp.200609648/DC1).
The role of PI(4,5)P2 in HCN channel gating was fi  rst 
studied by application of exogenous PI(4,5)P2 to inside-
out patches after rundown was complete. Bath applica-
tion of 1 μM PI(4,5)P2 isolated from native tissues, 
which consists predominantly of phosphatidylinositol 
4,5-bisphosphate with an arachidonyl acyl chain in 
position 2 and a stearyl acyl chain at position 3 (AASt) 
(Rohacs et al., 2002), produced a large, gradual positive 
shift in the voltage dependence of HCN2 activation 
(Fig. 1, A and C). The time course of the shift in V1/2 
upon application of PI(4,5)P2 was fi  t by a single expo-
nential function with a t1/2 value (time to produce a half 
maximal effect) of  250 s. The average shift in V1/2 after 
28 min of exposure to phospholipid was +31.8 ± 5.1 mV 
(n = 4; see Fig. 3 B).
Given the slow rate at which native PI(4,5)P2 altered 
the voltage-dependent activation of HCN2, we next ex-
amined the short-acyl chain analogue of PI(4,5)P2, 
  dioctanoyl phosphatidylinositol 4,5-bisphosphate (diC8 
PI(4,5)P2), since this analogue has been reported to act 
more rapidly than long chain lipids (Rohacs et al., 
2002). Application of 25 μM diC8 PI(4,5)P2 caused a 
signifi  cant positive shift in the activation curve of HCN2, 
which occurred more quickly but was smaller in magni-
tude than the shift caused by 1 μM AASt PI(4,5)P2 
(Fig. 1, B and D). The onset of the shift in V1/2 with diC8 
PI(4,5)P2 (n = 10) had a t1/2 value of 86 s, three times 
faster than the effect of full-length PI(4,5)P2 (the in-
creased rate of action of diC8 PI(4,5)P2 may refl  ect the 
fact that it needed to be applied at a higher concentra-
tion than the more potent full-length AASt PI(4,5)P2). 
The average shift in V1/2 of HCN2 after 10 min expo-
sure to 25 μM diC8 PI(4,5)P2 was +15.4 ± 0.8 mV (n = 12; 
see Fig. 3 B), and there was a dose-dependent relation 
between the shift in V1/2 and the concentration of diC8 
PI(4,5)P2 (Fig. 2 A). A fi  t of the Hill equation to the 
dose–response curve yielded a value for the maximal 
shift in V1/2 of +20.9 mV, a K1/2 value of 10.9 μM, and a 
Hill coeffi  cient (h) of 1.11.
Both full-length PI(4,5)P2 and diC8 PI(4,5)P2 had a 
variable effect on the peak tail current amplitude after 
steps to negative voltages where voltage-dependent acti-
vation was complete (see Fig. S2). On average, there 
was a small decrease in peak current amplitude with 
both 25 μM full-length PI(4,5)P2 (37.1% ± 18.7% 
  decrease; range of 0.7% increase to 88.0% decrease; n = 4) 
and 25 μM diC8 PI(4,5)P2 (36.2% ± 6.8% decrease; 
range of 6.8% increase to 73.3% decrease; n = 12). 
However, these changes were not statistically signifi  cant 
when the effects of PI(4,5)P2 were analyzed over an entire 
dose–response curve, including control experiments 
without PI(4,5)P2 application (13.1 ± 1.6% decrease; 
n = 3; P > 0.35; ANOVA).
We next examined the effects of diC8 PI(4,5)P2 on 
the activation and deactivation kinetics of HCN2 chan-
nels (Fig. 2 B). Currents during hyperpolarizing volt-
age steps were fi  t with a single exponential to determine 
an effective time constant of activation. There was no 
signifi  cant effect of PI(4,5)P2 on the time constant of 596 Regulation of HCN Channel Gating and Rundown by PIP2
activation with steps to −115 or −125 mV. However, we 
observed a signifi  cant slowing of activation with steps to 
−135 mV (P < 0.02; t test). We also observed a signifi  -
cant twofold slowing in the rate of channel deactiva-
tion, measured by the time constant of tail current 
decay upon return of the membrane to −40 mV (P < 
0.001; t test).
Speciﬁ  city Proﬁ  le of HCN2 for Dioctanoyl 
Phosphatidylinositol Phosphates
Different PI(4,5)P2 binding domains and PI(4,5)P2-
  regulated ion channels show varying degrees of speci-
fi  city for PI(4,5)P2 versus phosphatidylinositides that 
contain different numbers and positions of phos-
phates on the inositol headgroup (Rohacs et al., 1999; 
McLaughlin et al., 2002). To determine the lipid speci-
fi  city profi  le for HCN2, we compared the actions of a 
variety of PI lipids, all applied at the same concentra-
tion (25 μM) (Fig. 3 A).
Application of dioctanoyl phosphatidylinositol (diC8 
PI), whose inositol headgroup is nonphosphorylated, 
produced no voltage shift in the HCN2 activation curve 
(−0.3 ± 1.7 mV, n = 3), indicating the need for one or 
more phosphate moieties (or alternatively, a require-
ment for a larger headgroup). A phosphoinositide with 
a single phosphate, dioctanoyl phosphatidylinositol 4-
phosphate (diC8 PI(4)P), produced a small 7.5 ± 2.0 
mV (n = 6) positive shift in the V1/2 that was signifi  -
cantly less than the 15.4-mV shift seen with 25 μM diC8 
PI(4,5)P2 (P < 0.02; ANOVA). Application of a bisphos-
phate isomer distinct from PI(4,5)P2, dioctanoyl phos-
phatidylinositol 3,4-bisphosphate (diC8 PI(3,4)P2), 
caused a 12.3 ± 1.8-mV depolarizing shift (n  = 7), 
whereas dioctanoyl phosphatidylinositol 3,4,5-trisphos-
phate (diC8 PI(3,4,5)P3) produced a 9.3 ± 1.8-mV de-
polarizing shift (n = 8). Although these responses to 
diC8 PI(3,4)P2 and diC8 PI(3,4,5)P3 were somewhat 
smaller than the response to diC8 PI(4,5)P2, the differ-
ences were not statistically signifi  cant. Thus HCN2 is 
relatively nonselective among the polyphosphoinositi-
des, although the inositol sugar of PI may need to be 
phosphorylated for modulation to occur.
ATP-sensitive K+ channels (KATP) are the least specifi  c 
of the inwardly rectifying K+ channels in their activa-
tion by phosphoinositides and are uniquely activated by 
long chain (LC) acyl-CoA, an effect that is thought to 
refl  ect this lack of specifi  city (Rohacs et al., 2003). Given 
the low phosphoinositide specifi  city of HCN2, we tested 
the ability of LC acyl-CoA to alter its gating. Bath appli-
cation of 1 μM Oleoyl CoA caused a +16.0 ± 1.7-mV 
Figure 1.  Phosphatidylinositol 
4,5-bisphosphate (PI(4,5)P2) 
and dioctanoyl phosphati-
dylinositol 4,5-bisphosphate 
(diC8 PI(4,5)P2) cause depo-
larizing shifts in the activa-
tion of HCN2. Macroscopic 
HCN2 currents are shown for 
individual inside-out patches 
in response to a series of 
  hyperpolarizing voltage steps. 
(A) Before (top) and after 
(bottom) a 15’ bath applica-
tion of 1 μM native PI(4,5)P2. 
(B) Before (top) and after 
(bottom) a 10’ bath applica-
tion of 25 μM diC8 PI(4,5)P2. 
(C and D) Normalized tail 
currents from A and B, re-
spectively, plotted as a func-
tion of test potential and fi  t 
with the Boltzmann equation. 
Data obtained in absence 
(fi   lled circles) or presence 
(open circles) of PI(4,5)P2 
and diC8 PI(4,5)P2 applica-
tion. Insets show expanded 
records of tail currents from 
A and B, measured at −40 mV.  Pian et al.  597
shift (n = 4) in the HCN2 activation curve that was com-
plete within 2 min. The magnitude of this effect was 
similar to the shift seen with 25 μM diC8 PI(4,5)P2 but 
signifi  cantly smaller than the shift seen with 1 μM na-
tive PI(4,5)P2 (Fig. 3 B). Thus, HCN2 and KATP appear 
to defi  ne a class of channels that respond to LC acyl-
CoA and exhibit a low phosphoinositide selectivity. It is 
interesting to note that fatty acyl-CoA is a major metabo-
lite of cardiac myocytes, suggesting a possible physiolog-
ical or pathophysiological role of this modulation.
Interaction of diC8 PI(4,5)P2 and cAMP
Because the effect of PI(4,5)P2 to shift the activation of 
HCN2 to positive voltages is qualitatively similar to the 
modulatory action of cAMP, we explored the possibility 
that these two compounds act through similar mecha-
nisms by determining whether cAMP application could 
occlude the response to diC8 PI(4,5)P2 (Fig. 4). Inside-out 
patches were initially exposed to a saturating concen-
tration of cAMP (10 μM), which resulted in a +15.5 ± 
0.6-mV shift in the V1/2 (n = 4). The subsequent addi-
tion of 25 μM diC8 PI(4,5)P2 in the continued presence 
of 10 μM cAMP produced a further shift of +9.5 ± 0.7 mV 
(n = 4), resulting in a cumulative shift in V1/2 of +25.0 ± 
0.7 mV (Fig. 4 A). Thus, application of a saturating con-
centration of cAMP did not completely block the effect 
of diC8 PI(4,5)P2. Nonetheless, the effect of the lipid in 
the presence of cAMP was signifi  cantly less than the 
15.4-mV shift in the absence of cAMP (P < 0.01; t test). 
This suggests that the two compounds bind to distinct 
sites but may recruit a convergent biophysical mecha-
nism to alter the gating of HCN channels.
An interaction between cAMP and diC8 PI(4,5)P2 was 
also seen in their effects on the kinetics of HCN2 tail 
Figure 2.  Action of diC8 PI(4,5)P2 on the gating of HCN2. (A) Dose–
response curve for shift in V1/2 (∆V1/2) as a function of concentra-
tion of diC8 PI(4,5)P2. Data fi  t with the Hill equation. (B) Time 
constants (τ) of HCN2 current activation (left) and deactivation 
(right) in absence (squares, solid line) and presence (circles, 
dashed line) of 25 μM diC8 PI(4,5)P2. The difference between the 
time constants of activation at −135 mV before (0.731 ± 0.079 s) 
and after (1.28 ± 0.22 s) diC8 PI(4,5)P2 application were statisti-
cally signifi  cant (*, P < 0.02, t test). The difference between the 
time constants of deactivation at −40 mV before (67.6 ± 5.0 ms) 
and after (136 ± 13 ms) diC8 PI(4,5)P2 application were also sta-
tistically signifi  cant (*, P < 0.001, t test).
Figure 3.  Shift in V1/2 of HCN2 depends on number and location 
of inositol phosphates and on acyl chain length. (A) V1/2 shifts 
with 10-min applications of dioctanoyl phosphatidylinositol (PI) 
(−0.3 ± 1.7 mV, n = 3), dioctanoyl phosphatidylinositol 4-phos-
phate (PI(4)P) (+7.5 ± 2.0 mV, n = 6), dioctanoyl phosphati-
dylinositol 3,4-bisphosphate (PI(3,4)P2) (+12.3 ± 1.8 mV, n = 7), 
dioctanoyl phosphatidylinositol 4,5-bisphosphate (PI(4,5)P2), and 
dioctanoyl phosphatidylinositol 3,4,5-trisphosphate (PI(3,4,5)P3) 
(+9.3 ± 1.8 mV, n = 8). Differences between the responses to 
diC8 PI(4,5)P2 and diC8 PI(3,4,5)P3 and between the responses 
to diC8 PI(4,5)P2 and diC8 PI(4)P are statistically signifi  cant (P < 
0.05; ANOVA, Post Hoc). (B) V1/2 shifts after 28-min application 
of 1 μM of native PI(4,5)P2 (+31.8 ± 5.1 mV, n = 4), 10-min 
  application of 25 μM diC8 PI(4,5)P2 (+15.4 ± 0.8 mV, n = 12), 
and 2-min application of 1 μM oleoyl coA (+16.0 ± 1.7 mV, n = 4).598 Regulation of HCN Channel Gating and Rundown by PIP2
current deactivation (Fig. 4 B). As discussed above, in 
the absence of cAMP, diC8 PI(4,5)P2 caused a signifi  cant 
slowing of tail current deactivation at −40 mV. cAMP 
also slowed the tail current kinetics at −40 mV and, 
  importantly, these effects were occluded by diC8 PI(4,5)P2. 
Thus, the rate of channel deactivation at −40 mV in 
the combined presence of cAMP and diC8 PI(4,5)P2 was 
similar to that observed in the presence of diC8 PI(4,5)P2 
alone, indicating that the two modulatory agents share 
certain common mechanisms of action.
We observed a more complex interaction between 
cAMP and diC8 PI(4,5)P2 on activation kinetics. As pre-
viously described, cAMP application markedly acceler-
ated HCN2 activation kinetics over a wide range of 
hyperpolarized voltages (Wainger et al., 2001; Fig. 4 B). 
In contrast, as mentioned above, diC8 PI(4,5)P2 caused 
a modest slowing of activation kinetics at very negative 
voltages (−135 mV), with no signifi  cant effect on activa-
tion kinetics at more positive potentials (see Fig. 2 B). 
However, when we applied diC8 PI(4,5)P2 in the pres-
ence of cAMP, the lipid now produced a signifi  cant 
speeding in the rate of channel activation (P < 0.02 at 
−105 mV and P < 0.001 at −95 mV; t test; Fig. 4 B) at 
less hyperpolarized voltages. These results reinforce the 
notion that cAMP and PIP2 alter channel gating through 
both shared and unique mechanisms.
cAMP and diC8 PI(4,5)P2 Shift HCN2 Activation 
through Distinct Transduction Mechanisms
To further investigate the relation between the ef-
fects of diC8 PI(4,5)P2 and cAMP on HCN2 gating, 
we next examined a mutant HCN2 channel in which 
a tripeptide sequence—Q450, E451, K452—in the 
fi  rst α helix of the C-linker region (which couples the 
transmembrane domain to the cyclic nucleotide bind-
ing domain) was replaced with a tripeptide sequence, 
FPN, present at the corresponding region of a cyclic 
nucleotide-gated channel β subunit. This mutation was 
previously found to reverse the normal polarity of cy-
clic nucleotide gating of HCN2 so that cAMP binding 
shifts voltage-dependent opening of the mutant in the 
hyperpolarizing direction (Zhou et al., 2004). Thus, 
if PI(4,5)P2 acts through a similar molecular mecha-
nism as does cAMP, FPN mutant channels should show 
a hyperpolarizing response to phospholipid. In fact, 
we found that diC8 PI(4,5)P2 facilitated the opening of 
HCN2/FPN channels, producing a normal-sized +13.9 
± 1.6-mV shift (n = 4; Fig. 4 A). Thus, PI(4,5)P2 must 
regulate HCN2 gating through a transduction mecha-
nism distinct from that used by cAMP, although the ef-
fects of the two modulators clearly interact at several 
different levels.
Rundown of HCN2 Due to Dephosphorylation 
of Endogenous PIP2
The above results clearly show that HCN2 is modulated 
by exogenous PI(4,5)P2. We next asked whether HCN2 
is also modulated by endogenous PI(4,5)P2 and whether 
the rundown upon patch excision may be due to hydro-
lysis of endogenous PI(4,5)P2 by membrane-bound lipid 
Figure 4.  Effects of cAMP and diC8 PI(4,5)P2 on V1/2 and chan-
nel kinetics are not independent. (A) Interaction of effects of 
cAMP and diC8 PI(4,5)P2 on V1/2. Bars show the following (from 
left to right): cAMP, shift in V1/2 in response to 10 μM cAMP; 
cAMP + PIP2, shift in V1/2 in response to 10 μM cAMP plus 25 μM 
diC8 PI(4,5)P2; PIP2 (during cAMP), the difference between the 
shift in V1/2 in response to cAMP plus diC8 PI(4,5)P2 and the shift 
produced by cAMP alone; PIP2, shift in response to 25 μM diC8 
PI(4,5)P2 alone; PIP2 (HCN2/FPN), shift of mutant channel in 
response to 25 μM diC8 PI(4,5)P2. The shift with diC8 PI(4,5)P2 in 
the presence of cAMP is less than the shift with diC8 PI(4,5)P2 
alone (PIP2) (*, P < 0.01, t test). Error bars show SEM. Number of 
experiments shown in each bar. (B) Interaction of effects of cAMP 
and diC8 PI(4,5)P2 on time constants (τ) of HCN2 activation (left 
axis) and deactivation (right axis). Squares, data obtained in ab-
sence of PIP2 and cAMP (solid line, n = 14); circles, data obtained 
in the presence of 25 μM diC8 PI(4,5)P2 (dashed line, n = 10); 
  triangles, data obtained in presence of 10 μM cAMP (dotted line, 
n = 4); inverted triangles, data obtained in combined presence of 
10 μM cAMP plus 25 μM diC8 PI(4,5)P2 (dash dotted line, n = 4). 
The difference between the time constant of activation at −105 
mV in the presence of cAMP (1.49 ± 0.20 s) versus that in the 
presence of cAMP and PIP2 (0.664 ± 0.056 s) was statistically sig-
nifi  cant (*, P < 0.02, t test). The difference between the time con-
stant of activation at −95 mV in the presence of cAMP (5.66 ± 
0.48 s) and in the presence of cAMP and PIP2 (2.18 ± 0.33 s) was 
also statistically signifi  cant (**, P < 0.001, t test).  Pian et al.  599
phosphatases, as observed for other channels (Logothetis 
and Zhang, 1999; Wu et al., 2002).
As a fi  rst test of this hypothesis, we examined run-
down in the presence of the nonspecifi  c phosphatase 
inhibitors fl  uoride (Fl−) and orthovanadate (VO4
3−), 
which should block or delay any rundown due to lipid 
dephosphorylation. Patches containing HCN2 were 
excised into normal bath solution or bath solution 
supplemented with 0.1 mM Fl− and 0.2 mM VO4
3− (FV 
bath solution; Fig. 5). 1 min after patch excision into 
normal bath solution, the V1/2 of HCN2 was −120.6 ± 
0.5 mV (n = 5). The V1/2 then remained relatively con-
stant over the next 10 min, indicating that rundown was 
normally complete within 1 min. However, 1 min after 
patch excision in FV solution, the V1/2 was signifi  cantly 
more depolarized than in normal solution (−112.8 ± 
0.5 mV; n = 4; P < 0.00001; t test). The V1/2 then grad-
ually shifted to more hyperpolarized potentials over 
the next 5–10 min. The V1/2 for HCN2 in patches ex-
cised in FV solution remained signifi  cantly positive to 
the V1/2 observed in normal bath solution up to 3 min 
after patch excision (P < 0.04; t test). However, by 5 min 
after patch excision, the difference was no longer sta-
tistically signifi  cant. Thus the phosphatase inhibitors 
fl  uoride and orthovanadate delayed but did not prevent 
HCN2 channel rundown, suggesting that phosphatase 
activity in the excised patch may contribute to HCN2 
channel rundown.
Previous studies suggest that lipid kinases remain asso-
ciated with the membrane in cell-free patches (e.g., 
Huang et al., 1998; Rohacs et al., 2002). Thus, as a fur-
ther test of the hypothesis that endogenous PI(4,5)P2 
contributes to the regulation of HCN2, we next examined 
whether the effects of rundown on the V1/2 could be re-
versed through lipid kinase-mediated phosphorylation. 
After allowing channel rundown in FV bath solution 
to reach completion, patches were perfused with FV bath 
solution plus 2 mM MgATP to promote phosphorylation. 
Under these conditions, the HCN2 activation curve 
gradually shifted to more depolarized potentials (Fig. 6 A), 
reaching an average maximal shift of +9.3 ± 1.4 mV 
(n = 4) with a t1/2 of 3.8 min (Fig. 6 B).
This effect of MgATP was due to lipid phosphoryla-
tion, as opposed to protein phosphorylation, since we 
found that the depolarizing shift with MgATP was 
blocked by the lipid kinase inhibitor wortmannin (15 μM). 
In the presence of wortmannin, MgATP produced only a 
−1.0 ± 1.0 mV (n = 4) shift in the V1/2. In the presence 
of DMSO alone (the vehicle for wortmannin), 
addition of MgATP shifted the V1/2 by +7.8 ± 1.1 mV 
(n = 4) (Fig. 6 B and Fig. 8), which was not signifi  cantly 
different from the MgATP-induced shift in the absence 
of DMSO (+9.3 mV; P > 0.5; ANOVA). The shifts with 
MgATP in the absence or presence of DMSO were both 
signifi  cantly greater than the shift in the presence of 
wortmannin (P < 0.05; ANOVA).
Figure 5.  Phosphatase inhibitors delay the rundown in V1/2. V1/2 
values were assessed after inside-out patches were excised into 
normal bath solution (circles) or FV bath solution to inhibit 
phosphatase activity (squares). The differences in respective V1/2 
  values measured 1 and 3 min after patch excision were statistically 
signifi  cant (*, P < 0.05, t test).
Figure 6.  Application of MgATP to inside-out patches shifts 
HCN2 activation to more positive voltages. (A) Time course of 
V1/2 of HCN2 in a single inside-out patch experiment showing 
rundown and response to MgATP. Experiment performed in FV 
solution to inhibit endogenous phosphatase activity. (B) Time 
course of average V1/2 shift after bath application of MgATP in 
absence (squares) or presence (inverted triangles) of 15 μM 
wortmannin to block PI kinases. For data in response to MgATP 
alone, the single exponential fi  t yielded values for the steady-state 
shift in V1/2 of +9.5 mV and a t1/2 of 3.8 min.600 Regulation of HCN Channel Gating and Rundown by PIP2
Next we examined the effect of reducing endogenous 
PI(4,5)P2 levels by applying to inside-out patches an 
anti-PI(4,5)P2 antibody (Huang et al., 1998). After run-
down had reached completion in normal solution, ap-
plication of 30.3 μg/ml anti-PI(4,5)P2 antibody caused 
an additional 8.8 ± 1.3 mV hyperpolarizing shift with 
a time course characterized by a t1/2 of 3.6 min (Fig. 7 B). 
Control experiments performed with a heat-inactivated 
anti-PI(4,5)P2 antibody or an unrelated antibody failed 
to produce a signifi  cant hyperpolarizing shift (Fig. 8). 
A further test of the role of endogenous PI(4,5)P2 came 
from experiments in which we applied to inside-out 
patches polylysine, a polycation that reduces the effec-
tive negative charge associated with lipid headgroups 
(Rohacs et al., 2002). Polylysine (25 μg/ml) caused an 
additional 11.5 ± 1.3- mV hyperpolarizing shift in the 
HCN2 activation curve (Fig. 8), similar to the effects of 
the anti-PI(4,5)P2 antibody, consistent with a regulatory 
function of endogenous phospholipid.
In addition to manipulating PI(4,5)P2 levels in inside-
out patches, we also examined the effects of reducing 
PI(4,5)P2 levels in the plasma membrane of intact 
  oocytes. Oocytes were incubated in 15 μM wortmannin 
for 30–40 min to block the fi  nal step in the biosynthetic 
pathway for PI(4,5)P2 (Doughman et al., 2003). As a 
control, other oocytes were incubated in 0.05% DMSO 
alone. Subsequently, the V1/2 values for HCN2 in the 
  intact oocytes were assessed under these two condi-
tions by two-microelectrode voltage clamp. Incubation 
in wortmannin caused a signifi  cant  hyperpolarizing 
shift in the V1/2 of −7.9 ± 1.0 mV relative to the control 
values (n = 12 pair). As this concentration of  wortmannin 
inhibits both PI-3 kinase and PI-4 kinase, we tested the 
effects of LY294002, a more specifi  c inhibitor of PI-3 
  kinase (Vlahos et al., 1994; Browaeys-Poly et al., 2000; 
Song and Ashcroft, 2001). There was no signifi  cant ef-
fect on the V1/2 when 20 μM LY294002 was applied to 
intact oocytes (−0.1 ± 1.9 mV shift relative to DMSO 
control), indicating a role for PI-4 kinase. Thus, the in-
hibitory action of wortmannin most likely indicates a 
role for basal levels of endogenous PI(4,5)P2 in regulat-
ing HCN2 gating in the intact oocyte (Fig. 8).
Finally, we attempted to elevate levels of PI(4,5)P2 in 
intact oocytes by overexpressing PIP5K (Winks et al., 2005). 
Figure 7.  Reducing endogenous PI(4,5)P2 levels shifts HCN2 
  activation to more negative voltages. (A) Time course of V1/2 in 
a single inside-out patch experiment in response to bath applica-
tion of 30.3 μg/ml of anti-PI(4,5)P2 antibody. (B) Time course of 
average V1/2 shifts after bath application of anti-PI(4,5)P2 anti-
body (squares) or heat-inactivated antibody (inverted triangles).
Figure 8.  Summary of effects of altering PI(4,5)P2 levels on 
HCN2 gating. Average shifts in V1/2 shown in response to vari-
ous agents using either inside-out patches (gray bars) or whole 
oocytes (open bars). From top to bottom: bath only (no treatment); 
2 mM MgATP (in FV solution, 0.05% DMSO); 2 mM MgATP plus 
15 μM wortmannin (in FV solution, 0.05% DMSO); 25 μg/ml 
poly-d-lysine; 30.3 μg/ml anti-PI(4,5)P2 antibody (αPIP2 Ab); 
30.3 μg/ml heat-inactivated anti-PI(4,5)P2 antibody; 30.3 μg/ml 
anti-granulocyte macrophage colony stimulating factor antibody 
(αGM-CSF Ab); V1/2 of HCN2 coexpressed with PI(4)P 5-kinase 
minus V1/2 of HCN2 expressed alone (PIP5K); V1/2 of HCN2 after 
30–40-min preincubation in 15 μM wortmannin and 0.05% 
DMSO minus V1/2 after preincubation in 0.05% DMSO alone 
(Wortmannin); V1/2 after 2-h preincubation in 20 μM LY294002 
and 0.1% DMSO minus V1/2 after preincubation in 0.1% DMSO 
alone (LY294002). Error bars show SEM. Number of experiments 
shown next to each bar (n).  Pian et al.  601
However, paired two-microelectrode voltage-clamp 
  recordings showed no effect of PIP5K overexpression 
(0.9 ± 0.9 mV difference), perhaps indicating that 
  endogenous PIP5K is not rate limiting for PI(4,5)P2 
production in the oocytes (Fig. 8).
Regulation of Native HCN Currents in Sinoatrial Node 
Cells by DiC8 PI(4,5)P2
Are native HCN currents in rabbit cardiac sinoatrial 
cells also regulated by exogenous PI(4,5)P2? To address 
this question, we evaluated the effect of intracellular 
  dialysis with diC8 PI(4,5)P2 on the normal rundown of 
sinoatrial HCN currents during whole cell recording. 
The voltage dependence of activation was assayed by a 
two-step voltage protocol (see Materials and methods), 
in the absence or in the presence of diC8 PI(4,5)P2 (200 
μM) in the patch pipette solution (Fig. 9 A). Activation 
curves determined in the presence or absence of diC8 
PI(4,5)P2 were identical when measured 1 min after the 
start of whole-cell recording, with V1/2 values of −58 mV 
(Fig. 9 B). However, after 14 min of whole cell record-
ing, the two activation curves were clearly different. In 
the absence of diC8 PI(4,5)P2, the V1/2 shifted to −86 mV, 
refl  ecting rundown. In contrast, with diC8 PI(4,5)P2 in 
the pipette solution, the V1/2 only shifted to −72 mV 
(Fig. 9 B). A plot of V1/2 versus duration of whole-cell 
recording revealed the progressive hyperpolarizing 
shift in the HCN activation curve, in both the absence 
and presence of diC8 PI(4,5)P2 (Fig. 9 C). However, 
diC8 PI(4,5)P2 clearly delayed the hyperpolarizing shift, 
with statistically signifi  cant positive shifts observed for 
the 8- and 14-min time points (P < 0.05).
DISCUSSION
The present study provides strong support for the view 
that PI(4,5)P2 regulates both recombinant HCN2 and 
native cardiac HCN channels and that its degradation 
Figure 9.  Effect of diC8 
PI(4,5)P2 on the rundown of 
the voltage dependence of 
activation for HCN currents 
in sinoatrial node cells. 
(A) Representative whole-cell 
currents evoked by stepping 
the membrane from a hold-
ing potential of −35 mV to 
voltages ranging from −25 to 
−70 mV in 15-mV incre-
ments. The recordings were 
acquired 1 min (top) and 
14 min (bottom) after mem-
brane rupture in the absence 
(left) and in the presence 
(right) of 200 μM diC8 
PI(4,5)P2 in the pipette solu-
tion. Hyperpolarizing test 
voltages indicated at right. 
(B) Mean tail current activa-
tion curves at 1 min (fi  lled 
symbols) and 14 min (open 
symbols) in the absence 
(squares) and in the presence 
of 200 μM diC8 PI(4,5)P2 
(circles). The curves show 
best fi   ts of the Boltzmann 
equation. Mean values of pa-
rameters from Boltzmann fi  ts 
of individual activation curves 
obtained 1 min after patch 
rupture in absence and pres-
ence of diC8 PI(4,5)P2 were, 
respectively, V1/2 = −58.0 ± 1.5 mV (n = 8) and −58.3 ± 1.7 mV (n = 8, P > 0.05); s = 8.5 ± 0.7 mV and 7.8 ± 0.2 mV (P > 0.05). 
Mean parameters from Boltzmann fi  ts obtained after 14 min of whole-cell recording in absence and presence of diC8 PI(4,5)P2 were, 
  respectively, V1/2 = −86.4 ± 2.8 mV (n = 6) and −72.4 ± 2.7 mV (n = 6, P < 0.05); s = 16.8 ± 1.3 mV and 12.9 ± 0.7 mV (P < 0.05). 
(C) Time course of rundown in V1/2 during whole cell recordings in the absence (squares) and in the presence (circles) of 200 μM diC8 
PI(4,5)P2. The two curves differ signifi  cantly at times indicated by asterisks. Values of V1/2 for 1- and 14-min points from B. For 8-min 
points, mean activation parameters in absence and presence of diC8 PI(4,5)P2 were, respectively, V1/2 = −70.9 ± 1.7 mV (n = 8) and 
−63.4 ± 1.6 mV (n = 8, P < 0.05) and s = 14.1 ± 0.3 mV and 10.9 ± 0.6 mV (P < 0.05). Data for B and C obtained from three animals. 
There was no difference in mean capacitance between the two groups (not depicted).602 Regulation of HCN Channel Gating and Rundown by PIP2
after patch excision contributes to channel rundown. 
Thus, application of exogenous PI(4,5)P2 reversed 
rundown, whereas sequestration of PI(4,5)P2 enhanced 
rundown. Moreover, rundown was slowed by inhibition 
of phosphatases and partly reversed when endogenous 
lipid kinases were supplied with MgATP. Finally, manip-
ulation of PI(4,5)P2 levels in intact oocytes also modu-
lated HCN2 gating.
Comparison of Effects of PIP2 on HCN2 
with Other Channels
HCN2 joins a growing list of channels regulated by 
PI(4,5)P2 (Suh and Hille, 2005). For some channels, 
such as TRPV1 (Chuang et al., 2001) and mammalian 
rod cyclic nucleotide-gated channels (Womack et al., 
2000), PI(4,5)P2 inhibits channel activity. However, for 
the majority of channels regulated by PI(4,5)P2, includ-
ing HCN2, PI(4,5)P2 is permissive for channel activity 
(Hilgemann et al., 2001). Previous studies that inves-
tigated the role of PI(4,5)P2 in channel regulation 
usually characterized changes in channel function in 
response to depletion or addition of phosphoinositides 
to intact membranes. Such studies with the family of in-
ward rectifying K+ channels (Kir) have demonstrated 
a spectrum of apparent PI(4,5)P2 affi  nities among dif-
ferent channels. Our experiments indicate that HCN2 
falls into the KATP class of channels with relative low 
specifi  city for phosphoinositides.
Although HCN2 showed a relatively low selectivity 
among the polyphosphoinositides, the channel may 
have a relatively high affi  nity for PI(4,5)P2. Channels 
that tightly bind PI(4,5)P2 show a very slow response to 
application of the anti-PI(4,5)P2 antibody, whereas 
channels that weakly bind PI(4,5)P2 are rapidly inhib-
ited by the antibody. For example, the high-affi  nity IRK1 
channel is inhibited by anti-PI(4,5)P2 antibody with a 
half-time of  90 s, whereas the low-affi  nity GIRK1/4 
and GIRK2 channels show half-maximal block in <10 s 
(Huang et al., 1998). Despite our having used slightly 
higher concentrations of antibody than used in the Kir 
studies, we found that HCN2 required >200 s for half-
maximal inhibition with the anti-PI(4,5)P2 antibody, 
suggesting that HCN2 has a high affi  nity for PI(4,5)P2 
(although we cannot rule out the possibility that the 
slow time course of inhibition is due to a particularly 
slow access of antibody to the inside membrane of the 
patch in our experiments). A high affi  nity of HCN2 for 
PI(4,5)P2 is consistent with the idea that this channel 
constitutively binds PI(4,5)P2 and that hydrolysis of 
this phospholipid underlies the ubiquitous rundown of 
HCN currents.
Interactions of cAMP and PIP2: Mechanistic Implications
Our results, unfortunately, do not provide a defi  nitive 
mechanism for how PI(4,5)P2 regulates HCN2 gating. 
However, a comparison with the modulatory effects of 
cAMP provides some interesting clues. The binding of 
cAMP to its C-terminal cyclic nucleotide binding do-
main is thought to facilitate HCN channel opening by 
relieving an inhibitory action of the C terminus on gat-
ing (Wainger et al., 2001). Moreover, the effect of cAMP 
binding to the CNBD is transduced into changes in 
channel opening through the intervening C-linker re-
gion (Chen et al., 2001). We fi  nd that a C-linker muta-
tion that reverses the polarity of cAMP action on voltage 
gating (Zhou et al., 2004) causes no change in PI(4,5)P2 
action, indicating that phospholipid must act through 
a distinct mechanism from cyclic nucleotide. However, 
our fi  nding that the effects of cAMP and PI(4,5)P2 are 
not completely additive suggests that the actions of 
these modulators may converge on some fi  nal mecha-
nistic step of gating, such as the opening of the channel 
gate at the inner surface of the membrane (Rothberg 
et al., 2003).
Potential Physiological Implications of Modulation by PIP2
Our study clearly demonstrates that changes in mem-
brane PI(4,5)P2 concentration can affect the gating of 
recombinant HCN2, with higher levels of PI(4,5)P2 
shifting gating to more positive potentials. In addition, 
we have shown in cells from rabbit sinoatrial node that 
diC8 PI(4,5)P2 also delays the onset of native channel 
rundown in whole cell recordings. These fi  ndings sug-
gest that native HCN channels are regulated by PI(4,5)P2 
and that the presence of this lipid is required to 
maintain the relatively depolarized range of activation 
of HCN channels that is required for their opening at 
physiologically relevant voltages. Moreover, given that 
rabbit sinoatrial node cells express primarily HCN4 and 
HCN1 (Shi et al., 1999), our results further indicate 
that PI(4,5)P2 is a general modulator of HCN channel 
function, and does not only target HCN2.
One important remaining question is whether HCN 
channel function is dynamically regulated in neurons or 
cardiac myocytes during signal transduction cascades that 
alter membrane levels of PI(4,5)P2. Receptor-mediated 
activation of phospholipase C results in a decrease in 
membrane concentration of PI(4,5)P2 that alters the ac-
tivity of a number of channels, including GIRK1/4 and 
KCNQ2/3 (Rohacs et al., 1999; Kobrinsky et al., 2000; 
Wu et al., 2002; Zhang et al., 2003; Cho et al., 2005). 
In sinoatrial node cells, a hyperpolarizing shift in HCN 
channel activation due to reduced levels of PI(4,5)P2 
would slow heart rate, similar to the action of nano-
molar concentrations of acetylcholine, which cause a 
hyperpolarizing shift in pacemaker current without af-
fecting other nodal currents (DiFrancesco et al., 1989). 
However, such regulation is most effective for chan-
nels with a relatively low affi  nity for PI(4,5)P2, which 
may or may not hold for HCN channels. In addition to 
acute regulation by receptor activation, basal levels of 
PI(4,5)P2 may also change during development, times   Pian et al.  603
of stress, or in disease states (Suchy et al., 1995; Soares 
et al., 1997; Pasquare et al., 2004; Suh and Hille, 2005); 
these changes could lead to more tonic changes in HCN 
channel function. Lastly, PI(4,5)P2 levels vary among 
the different membrane compartments of a cell. Thus, 
a stimulatory effect of PI(4,5)P2 may allow the cell to re-
strict channel activity as channels are transported from 
their site of synthesis in the endoplasmic reticulum to 
fi  nal destinations with more permissive phosphoinositide 
concentrations (Hilgemann et al., 2001; Suh and Hille, 
2005). Further studies will be required to determine 
the physiological importance of the regulation of HCN 
channels by PI(4,5)P2.
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